Zai Lab Announces Participation at Upcoming May Conferences
SHANGHAI, China, May 09, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that members of the senior management team will participate in four upcoming conferences in May. Details of the conferences are as follows:
-- J.P. Morgan Global China Summit 2019
Date: May 8-9, 2019 Location: China World Summit Wing, Beijing
-- Bank of America Merrill Lynch Healthcare Conference 2019
Date: May 14-16, 2019 Location: Encore Hotel, Las Vegas
-- Macquarie Greater China Conference
Date: May 16-17, 2019 Location: Island Shangri-La Hotel, Hong Kong
-- Bank of America Merrill Lynch Innovative China Conference 2019
Date: May 27-28, 2019 Location: Futian Shangri-La Hotel, Shenzhen
Individuals may access more information on the Zai Lab website at www.zailaboratory.com under “Events & Presentations” in the “Investors” section.
About Zai Lab
Zai Lab (NASDAQ: ZLAB) is a China and US-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China’s pharmaceutical market and addressing unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners’ and its own products in order to impact human health worldwide.
Zai LabBilly Cho, CFO+86 137 6151 2501 firstname.lastname@example.org
Media: Nancie Steinberg / Robert FlammBurns McClellan, on behalf of Zai Lab212-213-0006, ext. 318 / 364, email@example.com / firstname.lastname@example.org
Investors: Jill SteierBurns McClellan, on behalf of Zai Lab212-213-0006, ext. 367, email@example.com